Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women

Reference

• Teede HJ, Lombard C, Deeks AA. Obesity, metabolic complications and the menopause: an opportunity for prevention. Climacteric 2010;13:203–209.
   PubMed Web of Science ®Google Scholar
• Tremblay AJ, Despres JP, Piche ME, Nadeau A, Bergeron J, Almeras N, Tremblay A, Lemieux S. Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism 2004;53:310–317.
   Google Scholar
• Kawai M, Devlin MJ, Rosen CJ. Fat targets for skeletal health. Nat Rev Rheumatol 2009;5:365–372.
   PubMed Web of Science ®Google Scholar
• Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006;2:35–43.
   PubMedGoogle Scholar
• Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197–207.
   PubMed Web of Science ®Google Scholar
• Lian JB, Gundberg CM. Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res 1988:267–291.
   PubMed Web of Science ®Google Scholar
• Puchacz E, Lian JB, Stein GS, Wozney J, Huebner K, Croce C. Chromosomal localization of the human osteocalcin gene. Endocrinology 1989;124:2648–2650.
   PubMed Web of Science ®Google Scholar
• Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456–469.
   PubMed Web of Science ®Google Scholar
• Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008;105:5266–5270.
   PubMed Web of Science ®Google Scholar
• Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, Faugere MC, Aja S, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010;142:309–319.
   PubMed Web of Science ®Google Scholar
• Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010;142:296–308.
   PubMed Web of Science ®Google Scholar
• Saleem U, Mosley TH, Jr., Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010;30:1474–1478.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009;94:827–832.
   PubMed Web of Science ®Google Scholar
• Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1–452.
   PubMed Web of Science ®Google Scholar
• Lindheim SR, Buchanan TA, Duffy DM, Vijod MA, Kojima T, Stanczyk FZ, Lobo RA. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig 1994;1:150–154.
   PubMedGoogle Scholar
• Patel SM, Iqbal N, Kaul S, Ratcliffe SJ, Rickels MR, Reilly MP, Scattergood T, Basu A, et al. Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial. Fertil Steril 2010;94:2161–2166.
   PubMed Web of Science ®Google Scholar
• Nasu M, Sugimoto T, Chihara M, Hiraumi M, Kurimoto F, Chihara K. Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: relationship with bone mineral density and lipid metabolism in perimenopausal women. Eur J Endocrinol 1997;136:608–616.
   PubMed Web of Science ®Google Scholar
• Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 1993;8:567–573.
   PubMed Web of Science ®Google Scholar
• Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998;78:783–809.
   PubMed Web of Science ®Google Scholar
• Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004;113:846–855.
   PubMed Web of Science ®Google Scholar
• Petzel M. Action of leptin on bone and its relationship to menopause. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:195–199.
   PubMedGoogle Scholar
• Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420–430.
   PubMed Web of Science ®Google Scholar
• Benayahu D, Shamay A, Wientroub S. Osteocalcin (BGP), gene expression, and protein production by marrow stromal adipocytes. Biochem Biophys Res Commun 1997;231:442–446.
   PubMed Web of Science ®Google Scholar
• Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448–452.
   PubMed Web of Science ®Google Scholar
• Liu SZ, Tian LF, Xu P, Zhuang GH, Zheng F, Tian J, Ning QL, Zhu BF, et al. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women. Mol Biol Rep 2011;38:939–948.
   PubMed Web of Science ®Google Scholar
• Scheven BA, Milne JS. Dehydroepiandrosterone (DHEA) and DHEA-S interact with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to stimulate human osteoblastic cell differentiation. Life Sci 1998;62:59–68.
   PubMed Web of Science ®Google Scholar
• Nabipour I, Larijani B, Beigi S, Jafari SM, Amiri M, Assadi M, Pazoki R, Amiri Z, et al. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study. Menopause 2008;15:934–939.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Livadas S, Katsikis I, Piperi C, Aimilia M, Papavassiliou AG, Panidis D. Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome. J Bone Miner Metab 2011;29:201–206.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin A, Cortes-Berdonces M, Luque-Fernandez I, Rozas-Moreno P, Quesada-Charneco M, Munoz-Torres M. Osteocalcin as a marker of metabolic risk in healthy postmenopausal women. Menopause 2011;18:537–541.
   PubMed Web of Science ®Google Scholar
• Usui C, Asaka M, Kawano H, Aoyama T, Ishijima T, Sakamoto S, Higuchi M. Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people. J Nutr Sci Vitaminol (Tokyo) 2010;56:109–116.
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Karter AJ, Festa A, D’Agostino R, Jr., Wagenknecht LE, Savage P, Tracy RP, Saad MF, et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:2642–2647.
   PubMed Web of Science ®Google Scholar
• Nagai M, Komiya H, Mori Y, Ohta T, Kasahara Y, Ikeda Y. Estimating visceral fat area by multifrequency bioelectrical impedance. Diabetes Care 2010;33:1077–1079.
   PubMed Web of Science ®Google Scholar